Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about JNJ
Recent news which mentions JNJ
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Johnson & Johnson's Tremfya Seeks Expanded Use Approval After It Shares Encouraging Late-Stage Study Data In Crohn's Disease
October 28, 2024
Tickers
JNJ
NEWS
Tags
Benzinga
Top Stories
Health Care
From
Benzinga
3 Dividend Growth Stocks You Can Buy and Hold Forever
October 26, 2024
Tickers
ABBV
ABT
JNJ
Tags
ABT
Market News
ABBV
From
Motley Fool
Johnson & Johnson's Blockbuster Drug Tremfya Clears Plaque Psoriasis With Lesions Covering Body's Smaller Areas
October 25, 2024
Tickers
JNJ
NEWS
Tags
JNJ
Briefs
Market News
From
Benzinga
Comparative Study: Johnson & Johnson And Industry Competitors In Pharmaceuticals Industry
October 24, 2024
Tickers
JNJ
NEWS
Tags
Market News
Markets
BZI/IA
From
Benzinga
Meet the Only 2 Game-Changing Businesses With a Higher Credit Rating Than the U.S. Government
October 24, 2024
Tickers
JNJ
MSFT
Tags
Market News
MSFT
Recent Press Releases
From
Motley Fool
3 Simple Vanguard ETFs to Buy With $1,000 and Hold for a Lifetime
October 23, 2024
Tickers
AAPL
ABBV
AMZN
AVGO
Tags
JNJ
GOOGL
BRK/B
From
Motley Fool
This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock
October 23, 2024
Tickers
BIIB
JNJ
LLY
Tags
Market News
BIIB
LLY
From
Motley Fool
Justice Department's Trustee Program Alleges Johnson & Johnson's Talc Litigation Bankruptcy Bid Is Bad-Faith Tactic To Avoid Liability
October 22, 2024
Tickers
JNJ
NEWS
Tags
News
General
Large Cap
From
Benzinga
Peering Into Johnson & Johnson's Recent Short Interest
October 22, 2024
Tickers
JNJ
Tags
Short Sellers
Benzinga
JNJ
From
Benzinga
What's Going On With Kenvue Stock Monday?
October 21, 2024
Tickers
HLN
JNJ
KVUE
NEWS
Tags
KVUE
HLN
Benzinga
From
Benzinga
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
October 20, 2024
Tickers
JNJ
KVUE
NEWS
Tags
News
Benzinga
KVUE
From
Benzinga
All It Takes Is $2,500 Invested in Each of These 3 High-Yield Dow Dividend Stocks to Help Generate Over $300 in Passive Income Per Year
October 19, 2024
Tickers
CVX
DJI
DOW
JNJ
Tags
Market News
JNJ
Recent Press Releases
From
Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
October 19, 2024
Tickers
ABT
JNJ
Tags
Recent Press Releases
JNJ
Market News
From
Motley Fool
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
October 18, 2024
Tickers
JNJ
NEWS
TYRA
Tags
Price Target
Expert Ideas
Stories That Matter
From
Benzinga
Johnson & Johnson Unusual Options Activity
October 18, 2024
Tickers
JNJ
Tags
Market News
Options
Markets
From
Benzinga
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
October 18, 2024
Tickers
ABT
JNJ
PFE
Tags
JNJ
Recent Press Releases
ABT
From
Motley Fool
This Magnificent Dividend Stock Is as Healthy as It Gets
October 17, 2024
Tickers
JNJ
Tags
Market News
Recent Press Releases
JNJ
From
Motley Fool
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
October 16, 2024
Tickers
JNJ
NEWS
Tags
Analyst Ratings
General
Benzinga
From
Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
October 16, 2024
Tickers
BMY
JNJ
Tags
JNJ
Recent Press Releases
BMY
From
Motley Fool
Cancer Drugs Propel J&J Beyond Wall Street Estimates
October 15, 2024
Tickers
JNJ
WBA
Tags
Benzinga
contributors
General
From
Benzinga
Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript
October 15, 2024
Tickers
JNJ
Tags
Recent Press Releases
JNJ
Market News
From
Motley Fool
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
October 15, 2024
Tickers
CDNA
ERIC
JNJ
MGTX
Tags
Market News
Equities
Markets
From
Benzinga
Chipmaker Stocks Sink On ASML Earnings Leak, Oil Eyes Worst 1-Day Drop This Year, Small Caps Rally: What's Driving Markets Tuesday?
October 15, 2024
Tickers
AAL
ARM
ASML
BAC
Tags
WBA
Equities
CCL
From
Benzinga
Google Goes Nuclear For AI Power, Israeli Restraint Impacts Stocks, Gold, And Oil
October 15, 2024
Tickers
AAPL
AMZN
BAC
CEG
Tags
META
QQQ
Benzinga
From
Benzinga
Johnson & Johnson's Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition
October 15, 2024
Tickers
JNJ
NEWS
Tags
Guidance
JNJ
Briefs
From
Benzinga
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
October 15, 2024
Tickers
AMD
BA
BAC
C
Tags
Top Stories
GS
BAC
From
Benzinga
Jim Cramer Says Earnings Season Will Fuel Market's Record Run, But Warns Of This 'Horrendous' Headwind That Could Apply Brakes To Rally
October 15, 2024
Tickers
BAC
C
GS
JBHT
Tags
SCHW
Analyst Color
Tom Lee
From
Benzinga
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
October 14, 2024
Tickers
JNJ
NEWS
Tags
Expert Ideas
Earnings
Price Target
From
Benzinga
This Is What Whales Are Betting On Johnson & Johnson
October 14, 2024
Tickers
JNJ
Tags
Benzinga
BZI/UOA
JNJ
From
Benzinga
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
October 14, 2024
Tickers
JNJ
LLY
NEWS
Tags
News
General
Large Cap
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.